Back to company

Boehringer Ingelheim Animal Health Denmark A/S: Financial statements 2016

CVR: 13526990

Boehringer Ingelheim Animal Health Denmark A/S (CVR 13526990) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 39,000,000 and a net result of DKK 3,876,000 compared with DKK 3,679,000 the year before. Equity amounted to DKK 27,603,000. The solvency ratio was 26.1%. The company had 31 employees in the financial year.

Gross Profit
39,000,000 kr.
Profit/Loss
3,876,000 kr.
Equity
27,603,000 kr.
Total Assets
105,916,000 kr.
Employees
31

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-39 mio.3.9 mio.27.6 mio.31
2015--3.7 mio.23.7 mio.35
2014-67.2 mio.5.8 mio.20 mio.29
2013-67.1 mio.6.4 mio.20.2 mio.29

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Boehringer Ingelheim Animal Health Denmark A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

Pierluigi Crippa joins the board of Boehringer Ingelheim Animal Health Denmark A/SDec 1, 2016

As of December 1, 2016, Pierluigi Crippa has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Peter Sjoerd Kuiper leaves the board of Boehringer Ingelheim Animal Health Denmark A/SDec 1, 2016

As of December 1, 2016, Peter Sjoerd Kuiper has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Boehringer Ingelheim Animal Health Denmark A/S: The 2015 annual report is outMay 30, 2016

Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2015. The net result was DKK 3,679,000.

About Boehringer Ingelheim Animal Health Denmark A/S

Boehringer Ingelheim Animal Health Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 1989. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERIAL NORDEN A/S and RHONE MERIEUX NORDEN A/S. The management consists of Dirk Neven Rauleder. The company is owned by Boehringer Ingelheim Animal Health International GmbH. The company has 95 employees. In 2025, the company reported revenue of DKK 725,936,000 and a net result of DKK -3,950,000 compared with DKK 40,407,000 the year before. Equity amounted to DKK 90,111,000.